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Abstract: Supplementation with anthocyanin-rich blackcurrant increases blood flow, cardiac 28 
output, and stroke volume at rest. It is not known if cardiovascular responses can be 29 
replicated over longer timeframes in fed trained cyclists. In a randomized, double-blind, 30 
crossover design, thirteen male trained cyclists (age 39 ± 10 years, ?̇?O2max 55.3 ± 6.7 31 
ml·kg−1·min−1) consumed two doses of New Zealand blackcurrant (NZBC) extract (300 and 600 32 
mg·day-1 for one week). Cardiovascular parameters were measured during rest and 33 
submaximal cycling (65% ?̇?O2max) on day 1 (D1), D4 and D7. Data were analyzed with a RM 34 
ANOVA using dose (PLA vs 300 vs 600 mg·day-1) by time point (D1, D4 and D7). Outcomes 35 
from PLA were averaged to determine the coefficient of variation (CV) within our 36 
experimental model, and 95%CI were examined for differences between PLA and NZBC. There 37 
were no differences in cardiovascular responses at rest between conditions and between 38 
days. During submaximal exercise, no positive changes were observed on D1 and D4 after 39 
consuming NZBC extract. On D7, intake of 600 mg increased stroke volume (3.08 ml, 95%CI: -40 
2.08, 8.26; d=0.16, p=0.21), cardiac output (0.39 L⋅min-1, 95%CI: -1.39, 0.60; d=0.14, p=0.40) 41 
(both +2.5%) and lowered total peripheral resistance by 6.5% (-0.46 mmHg⋅min⋅mL-1, 95%CI: 42 
-1.80, 0.89; d=0.18, p=0.46). However, these changes were trivial and fell within the CV of our 43 
study design. Therefore, we can conclude that NZBC extract was not effective in enhancing 44 
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During endurance exercise, the increment in oxygen consumption is predominantly dictated 52 
by the metabolic demand of skeletal muscles. Cardiac output increases to meet the oxygen 53 
demand during endurance exercise (Hellsten and Nyberg, 2016). Elite athletes can sustain 54 
high intensity workload (85% ?̇?O2max) for several hours, with cardiac output reaching up to 55 
35-40 L·min-1 (Ekblom and Hermansen, 1968). Therefore, oxygen delivery at a given workload 56 
is paramount to sustain muscle contractions during high intensity endurance exercise.  57 
In the last decade, fruit-derived (e.g. blackcurrant, chokeberry and blueberries) supplements 58 
have been examined due to their ability to ameliorate cardiovascular function, reducing 59 
oxidative stress and inflammation (e.g. cherry, Bell et al., 2015). Berries are rich in 60 
anthocyanins, water soluble molecules that belong to the flavonoid group of polyphenols and 61 
responsible for the red, blue and purple colours of plant and fruits (Harborne & Grayer, 1988). 62 
A recent meta-analysis showed that acute and chronic consumption of anthocyanins can 63 
improve flow mediated dilatation (FMD) (Fairlie-Jones et al., 2017). In vitro studies have 64 
shown that anthocyanins play a role in vascular health. Anthocyanins enter the endothelial 65 
smooth cells (Ziberna et al., 2012) and enhance gene expression of endothelial nitric oxide 66 
synthase (eNOS), an enzyme responsible for production of the vasodilator nitric oxide (NO) 67 
(Xu et al., 2004). Matsumoto et al., (2005) observed that acute intake of 17 mg·kg-1 of 68 
blackcurrant concentrate increased forearm blood flow by 1.22 (0.13)-fold, 2 h post ingestion. 69 
This response seems to be dose dependent reaching a plateau around intake of 310 mg of 70 
anthocyanins (Rodriguez-Mateos et al., 2013). The rise in blood flow coincided with peak 71 
plasma anthocyanin (Czank et al., 2013). However, anthocyanins are rapidly metabolized and 72 
their products are still present in the plasma up to 48 h (de Ferrars et al., 2014). These second 73 
phase metabolites seem to be beneficial to vascular function by increasing NO bioavailability 74 
via reduction of nicotinamide adenine nucleotide (NADH) activity (Rodriguez-Mateos et al., 75 
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2013). Therefore, studies of anthocyanin-rich supplements have implemented strategies for 76 
short-term intake (e.g. 7 days) based on the premise of the build-up of metabolites in tissues 77 
and plasma over time. Willems et al., (2015) showed that consuming ~138 mg of anthocyanins 78 
from New Zealand blackcurrant powder improved cardiac output and stroke volume, 79 
reducing total peripheral resistance in endurance-trained subjects at rest. Similarly, Cook et 80 
al., (2017) reported a dose-response effect at rest when consuming 300, 600 and 900 mg of 81 
New Zealand blackcurrant extract (NZBC) for 7 days. It is not clear if these benefits persist 82 
during exercise. Two studies reported some beneficial effects during typing exercise 83 
(Matsumoto et al., 2005) and sustained isometric contractions (Cook et al., 2017) and one 84 
study showing no effects during submaximal cycling (Willems et al., 2015). However, these 85 
studies were conducted in the morning after light breakfast (Willems et al., 2015; Cook et al., 86 
2017), or under food restrictions avoiding polyphenol intake (Matsumoto et al., 2005; 87 
Rodriguez-Mateos et al., 2013) and examined only once the effects of anthocyanins against 88 
placebo.  89 
However, in real-life scenarios, athletes will consume foods and sports supplements before 90 
competition and there might be occasions where they are required to race multiple times 91 
over short period (Burke, 2017). The effects of anthocyanin intake on cardiovascular 92 
parameters are unknown when being in a fed state . To address this, we examined the acute 93 
and short-term effects (4 and 7 days) of two dosages (300 and 600 mg) of NZBC extract on 94 
cardiovascular responses during rest and submaximal cycling in endurance fed trained 95 
cyclists. We hypothesized that intake of NZBC would improve cardiovascular activity at rest 96 
and during exercise mainly through an increment in cardiac output and stroke volume with a 97 
reduction in total peripheral resistance in a dose-dependent manner. 98 
 99 
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Materials and Methods 100 
Participants 101 
Thirteen male endurance-trained cyclists (age 39 ± 10 years, height 178 ± 7 cm, weight 75 ± 6 102 
kg, body fat 18 ± 4%, ?̇?O2max 55.3 ± 6.7 ml·kg−1·min−1, Wmax 372 ± 53 Watts) volunteered. 103 
Power analysis indicated that a sample size of 13 would allow detection of a moderate effect 104 
size (d=0.4) in cardiovascular function with a high statistical power (1–β =0.80; 0.05=α level). 105 
Participants were included in the study if healthy with more than one year of cycling club 106 
experience, cycling 8-10 hrs a week, not being involved in a structured training program, and 107 
not taking nutritional supplements. Before starting, participants provided written informed 108 
consent and completed a food frequency questionnaire for calculation of total anthocyanin 109 
intake using the phenol explorer database (Neveu et al., 2010). Anthocyanin intake was 46 ± 110 
13 mg·day−1. The study was approved by the University of Chichester Research Ethics 111 
Committee (code: 1718_30, approval date: 09 February 2018) with procedures conformed to 112 
the 2013 Declaration of Helsinki. 113 
 114 
Study design  115 
The study design was a randomized, double-blind, control trial to examine the effects of two 116 
doses of NZBC extract (300 or 600 mg) on cardiovascular parameters. Randomization and 117 
capsule preparation were performed by METW using http://www.randomization.com. The 118 
study involved 11 visits consisting of two familiarization sessions and in three separate weeks 119 
the three visits per week for each condition. In the first visit, the relationship between power 120 
output and oxygen uptake was determined using an incremental intensity cycling test. During 121 
the second visit, maximal oxygen uptake (?̇?O2max) and maximal work rate (Wmax) were 122 
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determined. The three visits for each condition were performed on day one (D1), D4 and D7. 123 
The recordings were taken at the same time of the day (± 2h) for each participant to minimize 124 
circadian variation. At the beginning of each visit, participants were weighted then rested for 125 
10 minutes in a supine position (Pickering et al., 2005). Thereafter, cardiovascular responses 126 
were recorded for 20 minutes using a beat-to-beat monitoring system (Finometer® PRO, 127 
Finapres Medical Systems BV, Amsterdam, The Netherlands) (details below). Participants 128 
then completed an incremental cycling test , rested 15 minutes, and then cycled for 10 min 129 
at sub-maximal intensity (65% ?̇?O2max) while cardiovascular responses were continuously 130 
recorded. Finally, participants completed a 16.1 km best effort TT (Montanari et al., 2020). 131 
On D7, one block was completed, and the same procedures were repeated for the remaining 132 
two conditions with at least 2 weeks washout between each block (Alvarez-Suarez et al., 133 
2014). Table 1 shows the allocation, time of testing and total time to complete the study. Due 134 
to the length of the study, completion time of the 11 visits was 6.6 ± 2.5 months.  135 
 136 
Incremental cycling test  137 
Participants cycled on a Lode ergometer (Lode BV, Groningen, Netherlands, and Ergoline, Bitz, 138 
Germany). The starting power was 50 W and increased by 30 W every 4 minutes, with 139 
participants keeping a pedal cadence between 70 and 90 rev·min-1. Within the last minute of 140 
each stage, an expired air sample was collected using Douglas bags (Cranlea & Co. Bourneville, 141 
Birmingham, UK) to establish the relationship between power output and oxygen 142 
consumption. Blood samples were collected with a finger prick to measure lactate 143 
concentration at the end of each stage (YSI 2300 Stat Plus, Yellow Springs Instruments Co. 144 
Inc., Yellow Springs, USA). On the first visit, the test ended when participants reached plasma 145 
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lactate value ≥ 4 mmol·L-1, whereas during the experimental visits, the protocol was 146 
interrupted two stages below participants’ onset of blood lactate accumulation of 4 mmol·L-147 
1. 148 
 149 
Maximal rate of oxygen uptake 150 
The test started at 50 W for 4 minutes, followed by incremental steps of 30 W every minute. 151 
Expired air was collected with Douglas bags during the last 3 minutes of the protocol. Maximal 152 
rate of oxygen uptake was achieved if the participants attained two of the following criteria: 153 
(1) blood plasma lactate ≥ 8 mmol·L-1, (2) plateau in ?̇?O2 of < 2.1 ml·kg−1·min−1 between the 154 
last two collections (3) respiratory exchange ratio (RER) ≥ 1.15 (Bassett & Howley, 2000). 155 
 156 
Cardiovascular measurements at rest and during submaximal exercise 157 
Cardiovascular parameters were recorded using a beat to beat blood pressure monitoring 158 
system (Finometer® PRO, Finapres Medical System BV, Amsterdam the Netherlands). For 159 
resting measurements, participants were in a supine position. A finger cuff was placed on the 160 
middle or ring finger with the arm crossed over the chest to minimize the hydrostatic height 161 
difference. Data were collected over 20 minutes and averaged over 10 consecutive seconds. 162 
The lowest systolic blood pressure value over 10 consecutive seconds and associated 163 
measurements were taken for analysis. During submaximal exercise, the cuff was positioned 164 
on the same finger and cardiovascular measurements were averaged for the last minute of 165 
the 10 minutes stage and taken for analysis. The cardiovascular parameters collected 166 
included: systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure 167 
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(MAP), heart rate (HR), stroke volume (SV), cardiac output (CO) and total peripheral resistance 168 
(TPR).  169 
 170 
New Zealand blackcurrant supplementation and diet standardization 171 
Participants consumed two capsules every day starting from D1 with the last intake on D7. 172 
Depending on the condition, intake consisted of one NZBC extract and one PLA capsule (300 173 
mg NZBC), two NZBC extract capsules (600 mg NZBC) or two PLA capsules (0 mg NZBC). Each 174 
NZBC extract capsule contained 105 mg of anthocyanins, consisting of 35–50% delphinidin-3-175 
rutinoside, 5–20% delphinidin-3-glucoside, 30–45% cyanidin-3-rutinoside, and 3–10% 176 
cyanidin-3-glucoside (CurraNZ™, Health Currancy Ltd, Surrey, UK) whereas PLA contained 300 177 
mg microcrystalline cellulose M102. Capsules were taken in the morning at breakfast except 178 
on the day of the experimental visits when intake was with a slice of buttered bread 2 h before 179 
arriving at the laboratory. Subsequently, participants were only allowed to consume water 180 
until the end of the experimental session. Blinding was successfully achieved via preparation 181 
of the conditions by a third-party researcher not involved in the data collection and analysis. 182 
Capsules were packed in pairs in single sealed plastic bags before handling to the participants 183 
who returned the empty plastic bags at the end of each block. None of the subjects could 184 
guess which condition they were taking during the study. 185 
For each session, participants avoided strenuous exercise for 48 h, and did no exercise and 186 
had no alcohol intake 24 h before each visit. Caffeine and energy drinks were not allowed for 187 
12 h prior the test. Lastly, prior to the first experimental visit, participants recorded their food 188 
intake for 24 h before and the same diet was replicated before each subsequent experimental 189 
visit. This method was selected to lower the participant’s burden throughout the study 190 
(Jeacocke & Burke, 2010). The diet was checked for adherence and compliance was 100%.  191 
Accepted version 09/09/2020, Int J Sport Nutr Exerc Metab,  
Statistical analysis 192 
 193 
Statistical analysis was completed using SPSS 23.0 (SPSS, Chicago, USA). The study was 194 
designed to allow a detection of 2–3 % difference in 16.1 km time-trial performance (1 − β 195 
=0.80: 0.05 =α level) (Cook et al., 2015). Data on blood lactate, substrate oxidation and TT 196 
performance are reported elsewhere (Montanari et al., 2020). Cardiovascular data at rest and 197 
during submaximal exercise were checked for homogeneity with the Mauchly test of 198 
sphericity and adjusted with the Greenhouse-Geisser test if violations were present. Normal 199 
distribution was assessed with the Shapiro-Wilk test. A RM ANOVA using a dose (PLA vs 300 200 
vs 600 mg·day-1) by time point (D1, D4 and D7) was implemented to investigate main effects 201 
for time dose and interaction. Pairwise comparisons were analysed using the least 202 
significance post-hoc test (LSD). Data of one participant was excluded from the cardiovascular 203 
responses during sub-maximal exercise due to recording errors. If main effects or interaction 204 
were observed, data are explored reporting mean difference and 95% confidence intervals 205 
(CI). The disposition of the mean difference in relation to the small worthwhile change (SWC) 206 
were investigated. The repeated data from PLA were averaged to determine the coefficient 207 
of variation (CV) and SWC for each cardiovascular parameter. The SWC was calculated 208 
multiplying the SD by 0.6 to account for higher variability of physiological parameters (Barroso 209 
et al., 2019).  All data were reported as mean ± SD unless stated otherwise. Effect size was 210 
interpreted using partial Cohen’s d values, with small (0.2) medium (0.5) and large (0.8) effect 211 
(Cohen, 1988). 212 
 213 
 214 
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Results 215 
NZBC extract and cardiovascular responses at rest 216 
Table 2 shows the data for the cardiovascular measurements at rest. There was no effect for 217 
time , condition  or interaction for SBP, DBP  and MAP.  Similarly, no differences were 218 
observed for HR, SV, CO, and TPR for time condition and interaction effect (Table 2).  219 
 220 
NZBC extract and cardiovascular responses during sub-maximal exercise  221 
 222 
Table 3 shows the average, CV and SWC for each cardiovascular response for PLA over the 223 
three tests compared to the observations on D1, D4 and D7 for 300 and 600mg.  224 
Data for SBP, DBP, MAP and HR showed no main effect for time, condition or interaction 225 
(Table 3). A significant effect for time was observed for CO (F(2,22)=5.11, p=0.015) with a 226 
medium effect size (d=0.68). Similarly, stroke volume and TPR showed a time effect 227 
(F(2,22)=7.49, p=0.003, d=0.81; F(2,22)=6.23, p=0.007, d=0.75, respectively) with no condition or 228 
interaction effects. Figure 1 shows the mean difference and 95% CI of 300 and 600 mg against 229 
PLA for SV, CO and TPR over the 3 days of testing. On D1, SV mean difference for 300 mg was 230 
lower than the SWC (-11.4 ml, 95%CI: -19.81, 2.97; d=0.55, p=0.013), and accompanied by a 231 
lower CO (-1.22 L⋅min-1, 95%CI: -2.12, 0.31; d= 0.42, p=0.013) and an increment in TPR (0.56 232 
mmHg⋅min⋅mL-1, 95%CI: -0.41, 1.55; d=0.18, p=0.48). This resulted in a decrement in SV and 233 
CO of 10 and 7%, respectively. A similar response was observed on D1 after intake of 600 mg 234 
with lower SV (-9.6 ml, 95%CI: -19.75, 0.58; d=0.43, p=0.06), CO (-1.35 L⋅min-1, 95%CI: -2.77, 235 
0.06; d=0.42, p=0.06) (both -8%) with an average increment of 0.68 mmHg⋅min⋅mL-1 for TPR 236 
(95%CI: -0.85, 2.21; d=0.21, p=0.46). On D4, all the cardiovascular parameters were within 237 
the range accounting for the SWC although TPR for 600 mg was close to the lower bound of 238 
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the SWC (-0.43 mmHg⋅min⋅mL-1, 95%CI: -1.69, 0.81; d=0.16, p=0.46). On D7 consuming 600 239 
mg raised SV (3.08 ml, 95%CI: -2.08, 8.26; d=0.16, p=0.21) CO (0.39 L⋅min-1, 95%CI: -1.39, 0.60; 240 
d=0.14, p=0.40) (both +2.5%) and lowered TPR by 6.5% (-0.46 mmHg⋅min⋅mL-1, 95%CI: -1.80, 241 
0.89; d=0.18, p=0.46), whereas intake of 300 mg did not provide any positive change (Figure 242 
1). 243 
Discussion 244 
This is the first study to examine the intake duration and dose-response effects of NZBC 245 
extract on cardiovascular responses at rest and during sub-maximal exercise in fed trained 246 
cyclists. In contrast to our initial hypothesis, NZBC failed to improve cardiovascular function 247 
at rest when compared to placebo. When we compared the effects of NZBC on cardiovascular 248 
function during sub-maximal exercise, we observed a decrement in SV and CO on D1 with 249 
both doses whereas only 600 mg raised SV and CO while lowering TPR on D7. However, the 250 
interpretation of these results needed careful consideration considering the strength and 251 
limitation of the current study design.  252 
In order to test the intake duration, participants performed a series of repeated tests over 253 
one week to examine acute and short-term (4 and 7 days) cardiovascular responses. The 254 
primary finding was that neither 300 nor 600 mg improved cardiovascular function at rest 255 
over this timeframe. These results are in contrast to some studies. Matsumoto et al., (2005) 256 
showed that acute intake of blackcurrant anthocyanins (17 mg·kg body weight-1) increased 257 
blood flow by 1.22 (0.13)-fold 2h post intake. In addition, Rodriguez-Mateos et al. (2013), 258 
demonstrated that acute anthocyanin intake, not only increased blood flow by 2.4 ± 0.5% at 259 
1 h, and 1.5 ± 0.4% at 2 h post intake, but this response was dose-dependent reaching a 260 
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plateau once participants consumed 310 mg of blueberry anthocyanins. Although we did not 261 
measure blood flow in the present study, we did not find changes in cardiovascular responses 262 
at rest following acute consumption of NZBC extract providing 105 and 210 mg of blackcurrant 263 
anthocyanins. Considering that the plateau effect observed by Rodriguez-Mateos et al. (2013) 264 
was 310 mg of anthocyanins, it is possible that the doses used were too low to produce a 265 
significant change in cardiovascular responses. Other reasons might be related with the 266 
participants’ condition (fed vs fasted), the control of the diet (polyphenol restriction vs normal 267 
diet habits) and the fitness status. It is known that endurance training improves cardiovascular 268 
responses at rest, lowering HR and blood pressure and increasing NOS expression (Green et 269 
al., 2016). Since endurance trained participants were recruited in the present study, it is 270 
possible that their cardiovascular function was already sufficiently adapted and therefore no 271 
significant changes were observed at rest. After ingestion, anthocyanins are quickly 272 
metabolised and excreted, therefore they present poor bioavailability (~12%) (Czank et al., 273 
2013). Nevertheless, their metabolites are still present in the plasma up to 48 h (de Ferrars et 274 
al., 2014). These metabolites are biologically active. In vitro studies showed that they can 275 
increase endothelial function reducing superoxide levels and increasing endothelial heme 276 
oxygenase-1 (Edwards et al., 2015), an enzyme reported to inhibit NADPH oxidase function 277 
(Jiang et al., 2006). Therefore, a short-term intake (≥ 48 h) should allow a build-up of the 278 
metabolites in the system. However, we did not find differences between conditions and 279 
within one week of NZBC extract intake on cardiovascular responses at rest. These results are 280 
in contrast with previous research of our own group that observed improved CO by 25%, and 281 
SV by 26% with a decrease in TPR by 16% in endurance trained athletes at rest (Willems et al., 282 
2015). Moreover, Cook et al., (2017) reported a dose-response effect for NZBC extract, with 283 
900 mg (315 mg of anthocyanins) providing no additional benefits compared to 600 mg (210 284 
Accepted version 09/09/2020, Int J Sport Nutr Exerc Metab,  
mg of anthocyanins). Difference in outcome might be related to the time of testing. Most of 285 
our participants (10 of 13) arrived in the afternoon and they were not fasted whereas previous 286 
data were based on morning recordings after an overnight fast. Consuming a meal causes an 287 
increment in HR, SV and CO affecting the cardiovascular system up to 2 h post ingestion 288 
(Sidery and Macdonald, 1994). Cook et al., (2017) reported an average CO at rest of ~4, ~4.5 289 
and ~4.8 L·min-1 for PLA, 300 and 600 mg of NZBC extract, respectively. In the present study, 290 
we recorded a higher average CO (>5 L·min-1) for all conditions at any time point, except for 291 
placebo intake at D7 (4.8 ± 0.9 L·min-1). Potentially, food intake close to visit time might have 292 
altered the cardiovascular response at rest. On a secondary note, we cannot exclude the 293 
intake of food interacting with anthocyanin absorption. It has been demonstrated that 294 
anthocyanin consumed with a high fat meal reached peak plasma concentration 4h post 295 
intake (Mazza et al. 2002). Using a rat model, Walton et al. (2009) reported lower plasma 296 
anthocyanin concentration when they were consumed with oats compared with water  297 
(Walton et al. 2009). We did not measure plasma anthocyanins levels, but we cannot exclude 298 
that the food consumed close to the dose on a testing day might have impaired and/or 299 
delayed anthocyanins absorption. More research in humans is warranted to better 300 
understand anthocyanins metabolism when consumed in proximity of other meals.  301 
In the present study, some cardiovascular responses during submaximal exercise showed 302 
positive changes after seven days of intake of 600 mg of NZBC extract. Specifically, we 303 
observed small increments in SV (+3.08 ml, +2.5%) CO (+0.39 L⋅min-1, +2.5%) and lower TPR 304 
by 6.5% (-0.46 mmHg⋅min⋅mL-1), whereas no beneficial changes were recorded for 300 mg. 305 
These data seem to support a dose relationship-effect observed in previous research 306 
(Rodriguez-Mateos et al., 2013; Cook et al., 2017). Using the same dosing strategy (600 mg), 307 
Cook et al. (2017) observed an increment of 0.6 L⋅min-1 and 5 ml for CO and SV respectively in 308 
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resting condition after seven days of intake with no significant difference in cardiovascular 309 
response at rest using 300 mg, therefore our results further support the intake of 600 mg of 310 
NZBC extract over the single dose.  311 
The observations in the present study must be interpreted with caution and the following 312 
limitations. Firstly, due to the condition of our study design, most of the participants were 313 
tested in the afternoon (10 of 13) and in a fed state. It is known that the circadian rhythm has 314 
an impact on the physiological responses of our body. Cugini et al., (1993) tracked the 315 
cardiovascular activity over a 24 h period showing that CO varied considerably over the day 316 
reporting a minimum of 6 L·min-1 and a maximum of 9.49 L·min-1. Similarly, SV showed a high 317 
variation with nocturnal values of 88 ml and a maximum diurnal values of 125 ml. Moreover, 318 
mean chronograms of the bioimpedance measurements showed how CO, SV, TPR, HR and 319 
blood pressure increased over time peaking in the afternoon/early evening. Therefore, it is 320 
possible that the daily variation in the cardiovascular activity might have been partially 321 
resulted from the natural rise in HR, CO an SV values potentially prohibiting blackcurrant 322 
effects. However, each participant was tested always at the same time of the day to minimize 323 
this variation. Secondly, it is worth noting that, on D1, we observed a drop in SV by 11 and 9 324 
ml for 300 and 600 mg compared to PLA with a moderate effect size. Such a difference is 325 
considered clinically relevant (Van Wolferen et al., 2011). This result was unexpected 326 
considering that there is no evidence of negative impact on SV and other cardiovascular 327 
parameters after acute and chronic intake of NZBC extract.  328 
In the present study, we determined a SWC of 3.8 ml, 0.5 L⋅min-1 and 0.36 mmHg⋅min⋅mL-1 329 
for SV, CO and TPR, respectively. However, the CV calculated over the three PLA tests showed 330 
a CV of 5% for SV and CO and 9% for TPR which translated in a potential variation of 6 ml for 331 
SV, 0.8 L⋅min-1 for CO and 0.66 mmHg⋅min⋅mL-1 for TPR. Similar variation was reported by 332 
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Waldron et al. (2018), using the Finapres as beat-to-beat monitoring system, with a CV of ~6% 333 
for SV during treadmill walk at 5% incline. Therefore, the CV might explain some of the 334 
variability observed on D1 as well as account for the small beneficial effects observed on D7 335 
for 600 mg. Other studies showed mixed results on the effects of NZBC extract on 336 
cardiovascular responses during exercise, reporting enhanced blood flow, CO and SV during 337 
2 minutes of sustained isometric contraction (Cook et al., 2017) or no effects during 338 
submaximal cycling  (Willems et al., 2015). The latter study showed that a sample of 9 would 339 
be needed to detect a difference of 20% in CO. For the present study, however, cardiovascular 340 
responses were not selected as primary outcomes. Data collected were part of a wider study 341 
project which included additional physiological (lactate levels, substrate oxidation) and 342 
performance parameters (16.1 km TT) as primary outcomes (Montanari et al., 2020). 343 
Therefore, our study might have been underpowered. Finally, although participants recruited 344 
were not involved in a structured training program, we did not measure the variation in 345 
training load and intensity across time to complete the whole study (6.6 ± 2.5 months). A 346 
recent study showed that participants often fail to replicate their physical activity routines 347 
before experimental trials (Chrzanowski-Smith et al., 2020). Therefore, future protocol should 348 
include more objective assessments (monitoring duration and intensity) to minimise day-to-349 
day variability in cardiovascular function using shorter study designs.  350 
In conclusion, the intake of NZBC extract does not affect cardiovascular responses in 351 
endurance trained fed male cyclists. Potential reasons for the present findings might be 352 
related to the time of testing, the duration of the study, the condition of the participants (fed) 353 
and the variation in the measurement recordings. Further research is required to understand 354 
anthocyanins metabolism and effects on cardiovascular responses using ecologically valid 355 
study designs.  356 
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 357 
Novelty Statement 358 
 • This is the first study examining the effects of New Zealand blackcurrant extract on 359 
cardiovascular responses at rest and during sub-maximal exercise after acute and short-term 360 
(4 and 7 days) intake in fed trained cyclists. New Zealand blackcurrant extract did not improve 361 
cardiovascular activity under these conditions.  362 
 363 
Practical Applications  364 
• If a supplementation protocol is considered by athletes and practitioners, 600 mg of New 365 
Zealand blackcurrant extract might provide trivial benefits after 7 days of intake without 366 
negative effects.  367 
• Supplementation of New Zealand blackcurrant extract should be carefully planned to avoid 368 
unknown interaction with other food matrixes that might affects its metabolism.  369 
 370 
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Table 1: Allocation, time of testing and time to complete the study. 1 = 300 mg; 2 = 600 mg; 3 = PLA. 518 
Participant Allocation Time of testing Completion time 
(months) 
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N1 1/2/3 6pm 8.5 
N2 2/1/3 6pm 8 
N3 3/2/1 3pm 8.5 
N4 3/1/2 6pm 8.5 
N5 3/2/1 9am 7 
N6 2/1/3 6pm 7 
N7 3/2/1 6pm 6,5 
N8 3/2/1 6pm 11 
N9 2/1/3 8am 3 
N10 3/2/1 6pm 5 
N11 1/3/2 9am 3 
N12 1/3/2 1pm 7 


















Table 2: Cardiovascular responses at rest for each condition on day 1 (D1), day 4 (D4) and day 7 (D7). Data are 536 
expressed as mean ± SD. 537 
Condition D1 D4 D7 
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SBP (mmHg)     
300mg 125 ± 13 130 ± 14 121 ± 14 
600mg 125 ± 11 125 ± 13 122 ± 13 
Placebo 121 ± 13 121 ± 14 123 ± 14 
DBP (mmHg)    
300mg 69 ± 9 73 ± 8 68 ± 8 
600mg 71 ± 9 69 ± 11 68 ± 9 
Placebo 66 ± 11 67 ± 9 69 ± 6 
MAP (mmHg)    
300mg 87 ± 11 92 ± 11 86 ± 10 
600mg 90 ± 10 87 ± 13. 87 ± 12 
Placebo 85 ± 13 85 ± 12 87 ± 9 
HR (bpm)    
300mg 56 ± 8 56 ± 8  55 ± 7 
600mg 54 ± 5 56 ± 7 55 ± 8 
Placebo 57 ± 8 55 ± 11 53 ± 5 
SV (ml)    
300mg 94 ± 11 94 ± 14 92 ± 13 
600mg 96 ± 12 95 ± 13 94 ± 12 
Placebo 97 ± 12 98 ± 14 90 ± 12 
CO (L·min-1)    
300mg 5.2 ± 1.0 5.2 ± 1.1 5.0 ± 1.0 
600mg 5.1 ± 0.8 5.2 ± 1.1 5.2 ± 1.0 
Placebo 5.4 ± 1.0 5.4 ± 0.6 4.8 ± 0.9 
TPR (mmHg⋅min⋅L-1)    
300mg 17.0 ± 3.8 18.2 ± 4.3 17.3 ± 2.9 
600mg 17.9 ± 3.9 17.1 ± 4.6 17.1 ± 4.5 
Placebo 16.3 ± 4.6 15.9 ± 2.8 18.4 ± 3.3 
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Note: systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate 538 
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 543 
Figure 1 - Difference in stroke volume, cardiac output and total peripheral resistance within each block for 544 
placebo, 300 mg and 600 mg. Values are expresses as difference mean per cell column (95% CI).   545 
 546 
 547 
Table 3: Cardiovascular responses during sub-maximal cycling (65% ?̇?O2max). Placebo (PLA) data are averaged 548 
over three tests on day 1 (D1), day 4 (D4) and day 7 (D7). Small worthwhile change (SWC). Coefficient of 549 
variation (CV). Data are expressed as mean ± SD. 550 
Note: systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate 551 
(HR), stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR).  552 
 553 
Cardiovascular responses at submaximal 
intensity (65% ?̇?O2max) 300 mg 600 mg 
Variable PLA SWC CV% D1 D4 D7 D1 D4 D7 
SBP (mmHg) 163 ± 7 4 4 170 ± 20 165 ± 19 166 ± 20 162 ± 23 160 ± 19 165 ± 17 
DBP (mmHg) 81 ± 5 3 7 88 ± 13 86 ± 10 87 ± 14 87 ± 14 83 ± 11 85 ± 11 
MAP (mmHg) 108 ± 6 4 6 115 ± 17 113 ± 13 114 ± 17 113 ± 16 109 ± 13 112 ± 13 
HR (bpm) 140 ± 3 2 2 143 ± 12 139 ± 12 142 ± 12 140 ± 14 140 ± 12 140 ± 12 
SV (ml) 120 ± 6 3.8 5 109 ± 20 118 ± 20 115 ± 26 111 ± 23 121 ± 19 123 ± 17 
CO (L·min-1) 16.8 ± 0.8 0.5 5 15.6 ± 2.8 16.5 ± 3.3 16.5 ± 3.8 15.5 ± 3.5 16.8 ± 2.6 17.3 ± 2.6 
TPR 
 (mmHg⋅min⋅L-1) 
7.15 ± 0.60 0.36 9 7.72 ± 2.56 7.24 ± 2.35 7.55 ± 3.27 7.83 ± 2.86 6.72 ± 1.84 6.68 ± 1.59 
